Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

256
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
256
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

73
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
73
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

127
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
127
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

689
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
689
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aberrant Right Subclavian Artery: A Case Report.

Cureus·2026
Same author

Producing concept-motivated signs supports learning of STEM in American Sign Language.

NPJ science of learning·2026
Same author

Enhancing COVID-19 Screening Models With Epidemiological and Mobility Features: Machine-Learning Model Study.

JMIR AI·2026
Same author

Simulation-Based Training in Intraosseous Access: Improving Procedural Skills in Pediatric Residents.

Sage open pediatrics·2025
Same author

IFNγ signaling drives resistance to FLT3 inhibition in acute myeloid leukemia.

iScience·2025
Same author

Infant dietary patterns and early childhood weight outcomes: a secondary analysis from the Starting Early Program Trial.

Research square·2025
Same journal

Vision-language models for human motion understanding: Lessons from stroke rehabilitation.

PLOS digital health·2026
Same journal

A digital marker for stratifying cardiovascular metabolic comorbidities among the middle-aged and elderly adults.

PLOS digital health·2026
Same journal

User engagement in the tuberculosis treatment support tools intervention and its impact on treatment outcomes: A secondary analysis of a pragmatic trial.

PLOS digital health·2026
Same journal

Machine learning for risk stratification of hypertensive disorders of pregnancy: Enhancing clinical efficiency in low-resource antenatal care in Tanzania.

PLOS digital health·2026
Same journal

The trust in AI-generated health advice (TAIGHA) scale and short version (TAIGHA-S): Development and validation study.

PLOS digital health·2026
Same journal

Time-series prediction of adverse birth outcomes in the U.S. using multilayer perceptron neural networks.

PLOS digital health·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Optimizing pharmacogenomic decision-making by data science.

Amir M Behdani1, Jessica Lai1, Christina Kim1

  • 1Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, United States of America.

PLOS Digital Health
|February 8, 2024
PubMed
Summary
This summary is machine-generated.

Patient Optimization Pharmacogenomics (POPGx) simplifies genotype-guided medication dosing for improved patient treatment. This tool helps healthcare providers optimize drug efficacy and safety by accessing pharmacogenomic data efficiently.

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Related Experiment Videos

Last Updated: Jul 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Area of Science:

  • Pharmacogenomics
  • Data Science in Healthcare
  • Precision Medicine

Background:

  • Medication effectiveness varies significantly between patients.
  • Genotype information can optimize patient treatment and dosing.
  • Current genetic dosing information retrieval is labor-intensive.

Purpose of the Study:

  • To describe the development of Patient Optimization Pharmacogenomics (POPGx).
  • To create a tool simplifying pharmacogenomic dosing recommendations for multi-medication regimens.
  • To educate patients on how genetic variations impact drug response.

Main Methods:

  • POPGx was developed using Konstanz Information Miner (KNIME), a code-free data analysis environment.
  • A KNIME REST API node was established to retrieve data from Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines.
  • The workflow processed drugs metabolized by CYP450 enzymes to demonstrate competency.

Main Results:

  • POPGx provides a time-efficient method for retrieving patient-specific medication and dosing recommendations.
  • The program automates the display of current CPIC guideline recommendations.
  • Users input genetic data and medication lists to receive clear dosing information.

Conclusions:

  • POPGx simplifies access to pharmacogenomic dosing information for healthcare providers.
  • The tool enhances clinical decision-making for improved medication efficacy and safety.
  • Integration into healthcare systems can revolutionize patient care through precision pharmacogenomics.